Volume 27, Issue 3 e15076
ORIGINAL ARTICLE

Factors associated with acute anterior uveitis history in patients with axial spondyloarthritis: Results of a longitudinal study

Haluk Cinakli

Corresponding Author

Haluk Cinakli

Division of Rheumatology, Kırklareli Education and Research Hospital, Kırklareli, Turkey

Correspondence

Haluk Cinakli, Division of Rheumatology, Kırklareli Education and Research Hospital, Kırklareli, Turkey.

Email: [email protected]

Search for more papers by this author
Elif Durak Ediboglu

Elif Durak Ediboglu

Division of Rheumatology, Hatay Education and Research Hospital, Hatay, Turkey

Search for more papers by this author
Dilek Solmaz

Dilek Solmaz

Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Izmir Katip Celebi University, Izmir, Turkey

Search for more papers by this author
Servet Akar

Servet Akar

Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Izmir Katip Celebi University, Izmir, Turkey

Search for more papers by this author
First published: 07 March 2024

Abstract

Backgrounds

Acute anterior uveitis (AAU) is the most common extra-musculoskeletal manifestation in axial spondyloarthritis (axSpA).

Objectives

The aim of the study is to evaluate the factors associated with AAU attacks in patients with axSpA during a 36-month follow-up period.

Methods

In total, 469 patients with axSpA were included in this observational study. Demographic data, clinical characteristics, disease activity measurements, and treatment patterns were compared between patients with and without a history of AAU. The development of AAU and its related factors were investigated using generalized estimating equations, which is a technique for longitudinal data analysis.

Results

Overall, 99 (21%) out of 469 patients experienced at least one AAU attack, with 77 patients (78%) having a history of AAU and 53 patients (58% of whom had a history of AAU) experiencing AAU attacks during the follow-up period. At baseline, patients with a history of AAU were found to be older (p = .001), be more likely to have peripheral arthritis (p < .001), have higher serum CRP levels (p = .016), have a higher frequency of sulfasalazine (SLZ) and tumor necrosis factor inhibitors (TNFi) use (p < .001 and p < .001, respectively). In the longitudinal analysis, having a history of AAU was identified as the only independent determinant of the development of AAU.

Conclusions

AAU history might be a risk factor for the development of AAU attacks in patients with axSpA. Although TNFi and SLZ were prescribed more frequently to patients with a history of AAU, the effectiveness of these agents in preventing further AAU attacks was not demonstrated.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflict of interest.

DATA AVAILABILITY STATEMENT

Data are available upon reasonable request by contacting the corresponding author.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.